User:George G. Papadeas/Sandbox VKOR
From Proteopedia
(Difference between revisions)
| Line 34: | Line 34: | ||
The most inexpensive and common way to treat blood clotting is through the VKOR inhibitor, <scene name='90/906893/Vkor_with_warfarin_bound/1'>Warfarin</scene>. [https://en.wikipedia.org/wiki/Warfarin Warfarin] is able to do so by outcompeting KO. It will enter the binding pocket of VKOR, creating strong hydrogen bonds with the active site. | The most inexpensive and common way to treat blood clotting is through the VKOR inhibitor, <scene name='90/906893/Vkor_with_warfarin_bound/1'>Warfarin</scene>. [https://en.wikipedia.org/wiki/Warfarin Warfarin] is able to do so by outcompeting KO. It will enter the binding pocket of VKOR, creating strong hydrogen bonds with the active site. | ||
=== Mutations === | === Mutations === | ||
| - | Some key <scene name='90/906893/Active_site_mutations/1'>mutations</scene> that can be detrimental to the VKOR structure are mutations of the <scene name='90/906893/Active_site/2'>active site</scene>. The two main residues, N80 and Y139, can be mutated to A80 and F139 creating a decrease in recognition and stabilization | + | Some key <scene name='90/906893/Active_site_mutations/1'>mutations</scene> that can be detrimental to the VKOR structure are mutations of the <scene name='90/906893/Active_site/2'>active site</scene>. The two main residues, N80 and Y139, can be mutated to A80 and F139 creating a decrease in recognition and stabilization. |
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
| Line 41: | Line 41: | ||
== References == | == References == | ||
1. Liu S, Li S, Shen G, Sukumar N, Krezel AM, Li W. Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation. Science. 2021 Jan 1;371(6524):eabc5667. doi: 10.1126/science.abc5667. Epub 2020 Nov 5. PMID: 33154105; PMCID: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946407/ PMC7946407]. | 1. Liu S, Li S, Shen G, Sukumar N, Krezel AM, Li W. Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation. Science. 2021 Jan 1;371(6524):eabc5667. doi: 10.1126/science.abc5667. Epub 2020 Nov 5. PMID: 33154105; PMCID: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946407/ PMC7946407]. | ||
| + | |||
| + | 2. “Warfarin.” Wikipedia, Wikimedia Foundation, 10 Feb. 2022, https://en.wikipedia.org/wiki/Warfarin. | ||
<references/> | <references/> | ||
Revision as of 22:07, 28 March 2022
| |||||||||||
References
1. Liu S, Li S, Shen G, Sukumar N, Krezel AM, Li W. Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation. Science. 2021 Jan 1;371(6524):eabc5667. doi: 10.1126/science.abc5667. Epub 2020 Nov 5. PMID: 33154105; PMCID: PMC7946407.
2. “Warfarin.” Wikipedia, Wikimedia Foundation, 10 Feb. 2022, https://en.wikipedia.org/wiki/Warfarin.
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
